Thomas W. Burke
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Duke University(US)Duke Institute for Health Innovation(US)Duke Medical Center(US)Duke University Hospital(US)
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Uterine Myomas and Treatments, Respiratory viral infections research, Cervical Cancer and HPV Research
Most-Cited Works
- → The downstream core promoter element, DPE, is conserved fromDrosophila to humans and is recognized by TAFII60 of Drosophila(1997)488 cited
- → Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters.(1996)412 cited
- → Gynecologic Cancer as a “Sentinel Cancer” for Women With Hereditary Nonpolyposis Colorectal Cancer Syndrome(2005)378 cited
- → Intraabdominal Lymphatic Mapping to Direct Selective Pelvic and Paraaortic Lymphadenectomy in Women with High- Risk Endometrial Cancer: Results of a Pilot Study(1996)367 cited
- → Risk Factors for Young Premenopausal Women With Endometrial Cancer(2005)360 cited
- → Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases(2003)